BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs3825942, CXCL2, Angiogenesis, Allergy to pollen, Lung, Autoimmunity, Ciprofibrate)
Bookmark Forward

QuickView for anticoagulant drugs (compound)


Genetic Markers

Most Correlated Genes

  1. CXCL6
  2. S100A9
  3. CXCL2
  4. ATF3
  5. CXCL1
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. response to organic substance
  2. PILON_KLF1_TARGETS_DN
  3. organic cyclic compound metabolic process
  4. heterocyclic compound binding
  5. organic cyclic compound binding
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Leukemia cell lines treated with DMSO or tanshinone IIA
  2. Dextran sulfate sodium induced colitis with and without methylthioadenosine treatment
  3. Human lung adenocarcinoma A549 cells treated with DAMTC
  4. Expression data for different phases of ulcerative colitis-associated carcinogenesis
  5. HepG2 cells treated with genotoxic and non-genotoxic agents
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Reversal of novel oral anticoagulants in patients with major bleeding.
  2. New antiplatelet and anticoagulant drugs. Considerations for dental patient management.
  3. Monitoring target specific anticoagulants.
  4. New anticoagulants and information].
  5. Laboratory monitoring of anticoagulant medications: focus on novel oral anticoagulants.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Effect of Anticoagulant Drug Intervention on Postoperative MALE and MACE in Patients With PAD
  2. Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation
  3. Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon
  4. DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers
  5. Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.